Invizius to Assess Way to Protect Peritoneal Membranes

The Invizius H-Guard Haemodialysis Priming Solution uses a novel protein to lines the inside of the dialyzer to make it more biocompatible. Next up? Investigating this technology to help people do PD longer, too.

Read the full article » | Posted 05-12-2022

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026